347740 — P&K Skin Research Center Co Cashflow Statement

0.000.00%

Last trade - 00:00

IndustrialsAdventurousMicro CapSuper Stock

Annual cashflow statement for P&K Skin Research Center Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	6,719	7,293	7,130	4,700	5,701
Depreciation
Non-Cash Items	721	-110	-829	-3,113	-3,194
Unusual Items
Other Non-Cash Items
Changes in Working Capital	382	-746	-262	2,227	4,677
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	8,666	7,697	7,507	5,549	9,032
Capital Expenditures	-1,055	-2,810	-1,356	-1,560	-622
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-36,357	-7,002	-2,964	2,532	-8,252
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-37,412	-9,812	-4,320	972	-8,874
Financing Cash Flow Items	-1,111	—	—	149	0
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	24,204	-264	284	-1,706	-3,495
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-4,541	-2,379	3,471	4,815	-3,336